BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20670144)

  • 1. Diagnostic pitfalls in syringocystadenocarcinoma papilliferum: case report and review of the literature.
    Leeborg N; Thompson M; Rossmiller S; Gross N; White C; Gatter K
    Arch Pathol Lab Med; 2010 Aug; 134(8):1205-9. PubMed ID: 20670144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syringocystadenoma papilliferum: Unusual location.
    Elfatoiki F; Khadir K; Ouakadi A; Azzouzi S; Bahechar N; Benchikhi H
    Dermatol Online J; 2011 Jun; 17(6):7. PubMed ID: 21696687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syringocystadenocarcinoma papilliferum with squamous cell carcinoma differentiation and with locoregional metastasis.
    Arslan H; Diyarbakrl M; Batur S; Demirkesen C
    J Craniofac Surg; 2013 Jan; 24(1):e38-40. PubMed ID: 23348331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syringocystadenocarcinoma papilliferum: a case report.
    Park SH; Shin YM; Shin DH; Choi JS; Kim KH
    J Korean Med Sci; 2007 Aug; 22(4):762-5. PubMed ID: 17728526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syringocystadenocarcinoma papilliferum in situ with pagetoid spread: a case report.
    Woestenborghs H; Van Eyken P; Dans A
    Histopathology; 2006 Jun; 48(7):869-70. PubMed ID: 16722938
    [No Abstract]   [Full Text] [Related]  

  • 6. Syringocystadenoma Papilliferum of Sweat Gland of Caruncle: A Unique Case Report.
    Raj A; Nagpal RC; Harsh M; Bahadur H
    Middle East Afr J Ophthalmol; 2017; 24(2):103-105. PubMed ID: 28936056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syringocystadenocarcinoma papilliferum in situ of the penis.
    Plant MA; Sade S; Hong C; Ghazarian DM
    Eur J Dermatol; 2012; 22(3):405-6. PubMed ID: 22510243
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of syringocystadenocarcinoma papilliferum in situ occurring partially in syringocystadenoma papilliferum.
    Arai Y; Kusakabe H; Kiyokane K
    J Dermatol; 2003 Feb; 30(2):146-50. PubMed ID: 12692383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphologic diversity of syringocystadenocarcinoma papilliferum based on a clinicopathologic study of 6 cases and review of the literature.
    Kazakov DV; Requena L; Kutzner H; Fernandez-Figueras MT; Kacerovska D; Mentzel T; Schwabbauer P; Michal M
    Am J Dermatopathol; 2010 Jun; 32(4):340-7. PubMed ID: 20216201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linear syringocystadenoma papilliferum: an unusual location.
    Pahwa P; Kaushal S; Gupta S; Khaitan BK; Sharma VK; Sethuraman G
    Pediatr Dermatol; 2011; 28(1):61-2. PubMed ID: 21276059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syringocystadenocarcinoma papilliferum in situ: report of a case with late recurrence.
    Castillo L; Moreno A; Tardío JC
    Am J Dermatopathol; 2014 Apr; 36(4):348-52. PubMed ID: 24394301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syringocystadenocarcinoma papilliferum with coexisting trichoblastoma: A case report with review of literature.
    Muthusamy RK; Mehta SS
    Indian J Dermatol Venereol Leprol; 2017; 83(5):574-576. PubMed ID: 28656914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syringocystadenoma papilliferum combined with a tubular apocrine adenoma.
    Léda LDSB; Lins MDSVS; Leite EJDS; Cardoso AEC; Houly RLS
    An Bras Dermatol; 2017; 92(5):721-723. PubMed ID: 29166517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syringocystadenocarcinoma papilliferum: a rare tumor with a favorable prognosis.
    Peterson J; Tefft K; Blackmon J; Rajpara A; Fraga G
    Dermatol Online J; 2013 Sep; 19(9):19620. PubMed ID: 24050294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare case of syringocystadenocarcinoma papilliferum of the breast: An institutional retrospective case review and brief literature review.
    McBride JD; Billings SD; Komforti MK
    J Cutan Pathol; 2021 Nov; 48(11):1387-1391. PubMed ID: 34089523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syringocystadenoma papilliferum arising on the scrotum.
    Goshima J; Hara H; Okada T; Suzuki H
    Eur J Dermatol; 2003; 13(3):271. PubMed ID: 12822557
    [No Abstract]   [Full Text] [Related]  

  • 17. Syringocystadenocarcinoma papilliferum of the eyelid.
    Hoguet AS; Dolphin K; McCormick SA; Milman T
    Ophthalmic Plast Reconstr Surg; 2012; 28(1):e27-9. PubMed ID: 22266788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syringocystadenocarcinoma papilliferum in situ originating from the perianal skin.
    Langner C; Ott A
    APMIS; 2009 Feb; 117(2):148-50. PubMed ID: 19239438
    [No Abstract]   [Full Text] [Related]  

  • 19. Syringocystadenocarcinoma papilliferum with transition to areas of squamous differentiation: a case report and review of the literature.
    Zhang YH; Wang WL; Rapini RP; Torres-Cabala C; Prieto VG; Curry JL
    Am J Dermatopathol; 2012 Jun; 34(4):428-33. PubMed ID: 22343110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal carcinoma arising from a syringocystadenoma papilliferum in a nevus sebaceus of Jadassohn.
    Hügel H; Requena L
    Am J Dermatopathol; 2003 Dec; 25(6):490-3. PubMed ID: 14631190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.